Clinical Trial With Combination of Dienogest/Ethytnilestradiol and Drosperidona/Ethyniestradiol
Status:
Withdrawn
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This trial will study the percentage of women with at least one occurrence of intracyclic
bleeding (bleeding and/or spotting) during the cycles 2 and 3 of treatment with test or
reference drug.